Given its dual role in cancer, targeting TLR4 for cancer therapy is complex but promising. Inhibitors of TLR4 are being explored as potential treatments to reduce inflammation and tumor growth. Conversely, TLR4 agonists are also being studied to boost the immune response against cancer cells. The therapeutic approach would depend on the specific cancer type and its microenvironment.
